Forskning ved Københavns Universitet - Københavns Universitet

Forside

NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

Publikation: Patent

Standard

NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT. / Thanh Tung, Truong (Opfinder); HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH (Opfinder).

IPC nr.: C07D277/44. Patentnummer: KR101384350 (B1). apr. 14, 2014.

Publikation: Patent

Harvard

Thanh Tung, T & HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH apr.. 14 2014, NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT, Patentnummer KR101384350 (B1), IPC nr. C07D277/44.

APA

Thanh Tung, T., & HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH (2013). IPC nr. C07D277/44. NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT. (Patentnummer KR101384350 (B1)).

Vancouver

Thanh Tung T, HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH, Opfindere. NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT. C07D277/44. 2013 dec 31.

Author

Thanh Tung, Truong (Opfinder) ; HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH (Opfinder). / NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT. IPC nr.: C07D277/44. Patentnummer: KR101384350 (B1). apr. 14, 2014.

Bibtex

@misc{a905469e8afa40c09ff418965bbe9553,
title = "NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT",
abstract = "The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.",
author = "{Thanh Tung}, Truong and {HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH}",
year = "2013",
month = "12",
day = "31",
language = "English",
type = "Patent",
note = "KR101384350 (B1); C07D277/44",

}

RIS

TY - PAT

T1 - NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

AU - Thanh Tung, Truong

AU - HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH

PY - 2013/12/31

Y1 - 2013/12/31

N2 - The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.

AB - The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.

M3 - Patent

M1 - KR101384350 (B1)

Y2 - 2014/04/14

ER -

ID: 130699254